Ardent Health Inc (ARDT) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ardent Health Inc   (NYSE: ARDT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Ardent Health Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Ardent Health Inc in the third quarter 2026?
Ardent Health Inc achieved a return on average equity (ROE) of 12.19 % in its third quarter 2026, which is below Ardent Health Inc 's average return on equity, which stands at 17.75%.

ROE has advanced compared to 9.92% in the second quarter 2026, due to net income growth.

Within the Healthcare Facilities industry 20 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 825 to 1036.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change 9.53 % 5.94 % 10.88 % 10.85 % -
Y / Y Net Income Change 3588.15 % -63.75 % -0.81 % -47.29 % -97.38 %
Net Income (TTM) in Millions 212 169 230 230 297
Return On Equity (TTM) 12.19 % 9.92 % 13.71 % 14.09 % 18.64 %
ARDT's Total Ranking # 1036 # 825 # 455 # 629 #
Equity (TTM) in Millions 1,789 1,746 1,735 1,686 1,633
Seq. Equity Change 2.46 % 0.64 % 2.89 % 3.24 % -0.9 %
Seq. Net Income Change 28.33 % -40.69 % -21.24 % 6052.61 % -98.74 %

Back to ARDT Management Effectiveness >> ARDT's 5 Years Annual ROE >> Compare ARDT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 21
Sector # 141
Overall # 1036

Return On Equity Statistics
High Average Low
23.33 %
17.75 %
9.92 %
(Dec 31 2024)   (Jun 30 2026)





ARDT Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024


Total Equity in Millions 1,686 1,521 0 0 0
Y / Y Equity Change 10.85 % - - - -
Net Income in Millions 230 300 0 0 0
Y / Y Net Income Change -23.21 % - - - -
Return On Equity 13.65 % 19.7 % - - -

Back to ARDT Management Effectiveness >> ARDT's 5 Years Annual ROE >> Compare ARDT ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 13.65 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ARDT's' Return on Equity at Yahoo Finance
ARDT's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ARDT's Competitors
Subscribers only: Roe for Ardent Health Inc 's Suppliers
Subscribers only: Return On Equity for ARDT's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Chemed Corporation  32.10 %
Illumina Inc   31.45 %
Transmedics Group Inc   28.74 %
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Beone Medicines Ltd   18.21 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %

Date modified: 2026-11-07T12:21:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.